• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » New CenterWatch study shows investigative sites see revenue, clinical trial volume growth amid signs of recovery

New CenterWatch study shows investigative sites see revenue, clinical trial volume growth amid signs of recovery

April 2, 2012
CenterWatch Staff

Investigative sites worldwide see encouraging signs of financial recovery, according to a new 2012 CenterWatch study benchmarking global investigative site workload, staffing and financial performance.  Results of the study, published in the April issue of The CenterWatch Monthly, reveal sites are rebounding, with growth in both headcount and revenue during the past year.

In its most extensive benchmark study of investigative site operations in a decade, CenterWatch has analyzed financial and operating data from 257 global sites.  The results offer valuable insights not only for investigative sites, but also for sponsors and CROs that manage research centers around the world. A complimentary sample of the summary report and data is available here. 

Although investigative sites report a 9.4% average operating margin, reports of annual profit growth are mixed: North American sites saw a decline in profitability, while European sites saw a 3.4% increase in profits between 2010 and 2011.  The study also finds that the typical investigative site saw growth in clinical trial activity and patient volume, as well as improved cash flow.

But sites remain cautious. While clinical trial activity is expected to increase in 2012, sites are wary about the lingering effects of poor global economic conditions and the majority does not plan to expand operations in 2012.

“The good news is that conditions are improving, but investigative sites are approaching the prospect of economic recovery with caution,” said CenterWatch COO Joan Chambers. “Although clinical grant spending and activity overall has increased, sites have been forced to manage in a tumultuous economic climate, and to do more with fewer dollars under ever tighter regulatory guidelines.”

In its May issue, CenterWatch will release part two of this study, comparing investigative site financial and operating benchmarks by research center size and for-profit and not-for-profit status.

Read an excerpt from this feature article, purchase a copy of the April issue or subscribe to The CenterWatch Monthly online at http://store.centerwatch.com, email sales@centerwatch.com or call (617) 948-5100. You’ll receive the full summary report with 20 data and methodology charts.

About CenterWatch

Founded in 1994, CenterWatch is a trusted source and global destination of clinical trials information for both professionals and patients. CenterWatch provides a wide variety of information services including grant leads for investigative sites; business development leads for contract service providers; postings of career opportunities; listings of clinical trials actively seeking patients; advertising and promotional opportunities; and proprietary business analysis and data about the global clinical trials industry. Visit www.centerwatch.com.

 

Contact:

Cheryl Rosenfeld

Editor-in-Chief

cheryl.rosenfeld@centerwatch.com

(617) 948-5172

 

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing